Details for New Drug Application (NDA): 076097
✉ Email this page to a colleague
NDA 076097 describes CARTEOLOL HYDROCHLORIDE, which is a drug marketed by Apotex Inc, Bausch And Lomb, and Sandoz, and is included in three NDAs. It is available from one supplier. Additional details are available on the CARTEOLOL HYDROCHLORIDE profile page.
The generic ingredient in CARTEOLOL HYDROCHLORIDE is carteolol hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the carteolol hydrochloride profile page.
The generic ingredient in CARTEOLOL HYDROCHLORIDE is carteolol hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the carteolol hydrochloride profile page.
Summary for 076097
| Tradename: | CARTEOLOL HYDROCHLORIDE |
| Applicant: | Apotex Inc |
| Ingredient: | carteolol hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 076097
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 1% | ||||
| Approval Date: | Feb 6, 2002 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
